ACHV compared with ALLO: revenue, margins and what each company keeps, and the suppliers and customers both name

ACHVAchieve Life Sciences, Inc.

Mkt capRevenueRevenue

ALLOAllogene Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ACHVAchieve Life Sciences, Inc.

ALLOAllogene Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ACHV 4

—Sopharma, ADunlistedsupplier

—University of Bristolunlistedsupplier

—Adare Pharma Solutionsunlistedsupplier

—Kristen Slaouiunlistedsupplier

Shared 0

No shared counterparties.

Only ALLO 12

PFEPfizersupplier

NTRANaterasupplier

CLLSCellectissupplier

—Arbor Biotechnologiesunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

8 more · ALLO chain ›

ACHVAchieve Life Sciences, Inc.

6.71▲+5.33%· post 6.71

Mkt cap$691.5MRevenue—

ALLOAllogene Therapeutics, Inc.

1.04▼−4.59%· post 1.07

ClosedNov 6 '26

Mkt cap$360.3MRevenue$5MQ2 FY26

Compare

ClosedNov 6 '26

ACHVAchieve Life Sciences, Inc.

ALLOAllogene Therapeutics, Inc.

6.71▲+5.33%post 6.71

Price

1.04▼−4.59%post 1.07

$691.5M

Mkt cap

$360.3M

—

Revenue

$5MQ2 FY26

ACHV6.71▲+5.33%vsALLO1.04▼−4.59%ClosedNov 6 '26